Edition:
United Kingdom

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

19.47USD
5:25pm BST
Change (% chg)

$-0.40 (-2.01%)
Prev Close
$19.87
Open
$19.83
Day's High
$19.84
Day's Low
$19.05
Volume
158,831
Avg. Vol
572,487
52-wk High
$53.90
52-wk Low
$11.50

About

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is... (more)

Overall

Beta: 1.95
Market Cap(Mil.): $1,050.50
Shares Outstanding(Mil.): 52.87
Dividend: --
Yield (%): --

Financials

  CLVS.OQ Industry Sector
P/E (TTM): -- 109.42 62.41
EPS (TTM): -7.06 -- --
ROI: -52.89 7.98 11.81
ROE: -143.16 8.13 12.64

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

12 Apr 2019

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

April 12 Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

12 Apr 2019

Earnings vs. Estimates